Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Baylor College of Medicine National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00903487 |
RATIONALE: Studying how men with localized prostate cancer managed their treatment-related side-effects may help doctors plan better treatment in the future.
PURPOSE: This clinical trial is studying treatment-caused symptom management in patients treated for localized prostate cancer.
Condition | Intervention |
---|---|
Prostate Cancer |
Other: informational intervention Procedure: assessment of therapy complications |
Study Type: | Interventional |
Study Design: | Health Services Research, Open Label |
Official Title: | A Qualitative Study of Prostate Cancer Symptom Management |
Estimated Enrollment: | 106 |
Study Start Date: | March 2008 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Using the qualitative data collected during a 2003-2005 study from University of California, San Francisco database of prostate cancer patients, their partners, and health-care providers that describe effective and ineffective symptom-management knowledge, skills, and behaviors in men treated for localized prostate cancer is analyzed. From these data a hierarchical classification or taxonomy of critical symptom-management competencies is developed, eventually developing instructional objectives for a tailored intervention to manage these patients' treatment-related side-effects and quality of life.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Texas | |
Dan L. Duncan Cancer Center at Baylor College of Medicine | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: David M. Latini, PhD 877-794-7852 canceroutcomes@bcm.edu |
Principal Investigator: | David M. Latini, PhD | Baylor College of Medicine |
Responsible Party: | Dan L. Duncan Cancer Center at Baylor College of Medicine ( David M. Latini ) |
Study ID Numbers: | CDR0000600458, BCM-H-19322 |
Study First Received: | May 15, 2009 |
Last Updated: | July 8, 2009 |
ClinicalTrials.gov Identifier: | NCT00903487 History of Changes |
Health Authority: | Unspecified |
stage I prostate cancer stage II prostate cancer stage III prostate cancer |
Prostatic Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |